Given a QuantiFERON‑TB Gold test with TB‑1 antigen 1.03 IU/mL, TB‑2 antigen 0.72 IU/mL, mitogen control 8.27 IU/mL, and nil 0.17 IU/mL, what is the likelihood of Mycobacterium tuberculosis infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

QuantiFERON-TB Gold Test Interpretation

Based on your QuantiFERON-TB Gold results (TB1-Nil = 1.03 IU/mL, TB2-Nil = 0.72 IU/mL), this test is POSITIVE for Mycobacterium tuberculosis infection, indicating a high likelihood of TB infection (either latent or active).

Test Interpretation Algorithm

Your results meet the established criteria for a positive QuantiFERON test 1, 2:

  • TB1 antigen response: 1.03 IU/mL (well above the 0.35 IU/mL cutoff)
  • TB2 antigen response: 0.72 IU/mL (also above the 0.35 IU/mL cutoff)
  • Mitogen control: 8.27 IU/mL (adequate, confirming viable T-cells)
  • Nil control: 0.17 IU/mL (acceptable background, <8.0 IU/mL)

Both TB antigen tubes exceed 0.35 IU/mL by substantial margins, and both responses are >25% greater than the nil control, satisfying all criteria for a positive result 1.

Clinical Significance

Your TB1 value of 1.03 IU/mL places you well above the "uncertainty zone" (0.2-0.7 IU/mL). Research demonstrates that individuals with interferon-gamma values >0.7 IU/mL have significantly higher rates of true TB infection 3. In fact, 87% of patients with active tuberculosis disease have values >0.7 IU/mL 3, and individuals with values >0.99 IU/mL who developed incident TB had a 0.97% progression rate within 3-24 months 4.

What This Means

  • This is NOT a borderline result requiring repeat testing. Both your TB1 (1.03) and TB2 (0.72) values are definitively positive 3, 4
  • The likelihood of this being a false positive is very low given both tubes are positive and values are well above cutoffs
  • You have evidence of TB infection - either latent tuberculosis infection (LTBI) or potentially active disease

Critical Next Steps

  1. Clinical evaluation for active TB disease is mandatory:

    • Assess for TB symptoms (cough >2-3 weeks, fever, night sweats, weight loss, hemoptysis)
    • Chest radiograph to rule out pulmonary TB
    • If symptomatic or abnormal chest X-ray: sputum cultures and molecular testing
  2. If active TB is ruled out:

    • You have latent TB infection (LTBI)
    • Treatment for LTBI should be strongly considered to prevent progression to active disease
    • Risk of progression is highest in the first 2 years after infection

Important Caveats

  • The TB2-TB1 difference (0.72 - 1.03 = -0.31 IU/mL) does NOT indicate recent vs. remote infection. Despite TB2 being designed to elicit CD8+ responses, research shows that TB2-TB1 differences >0.6 IU/mL do not reliably distinguish recent from remote TB exposure 5
  • Your mitogen control is robust (8.27 IU/mL), confirming your immune system is functioning properly and the test is valid
  • This test does not distinguish between latent and active TB - clinical and radiographic evaluation is essential 1

The positive result in both antigen tubes with values well above established thresholds indicates definite TB infection requiring clinical follow-up and consideration for treatment 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.